Comic Relief: Graphic Medicine as Care for Caregivers
Public ClinicalTrials.gov record NCT07207265. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Community care workers have been stretched to their capacity and exposed to ongoing trauma through their work addressing persistent health disparities in Inland Empire communities. The coronavirus pandemic and gap in Covid-19 mortality for minorities have highlighted the chronic stressors of racial injustice and dispossession that predate the pandemic and explain why these populations have higher comorbidities. While the pandemic has exacerbated ongoing stressors, the map of this crisis of care may show the way to deeper solutions. The premise of this project is that care occurs in a continuum of caretakers who also require care. The proposal seeks to address and complicate the question: who cares for the caregivers? This study will interrogate the benefits of providing a comics-making workshop, combined with trauma education and somatic experiencing, as a set of resiliency tools for care providers working with traumatized populations.
Study identification
- NCT ID
- NCT07207265
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 13 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 13, 2023
- Primary completion
- Apr 11, 2024
- Completion
- Apr 11, 2024
- Last update posted
- Oct 2, 2025
2023 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Riverside, California | Riverside | California | 92521 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07207265, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2025 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07207265 live on ClinicalTrials.gov.